Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Background Debate exists as to whether the higher hemoglobin A1c (HbA1c) levels observed in black persons than in white persons are due to worse glycemic control or racial differences in the glycation of hemoglobin. Objective To determine whether a racial difference exists in the relationship of mean glucose and HbA1c. Design Prospective, 12-week observational study. Setting 10 diabetes centers in the United States. Participants 104 black persons and 104 white persons aged 8 years or older who had had type 1 diabetes for at least 2 years and had an HbA1c level of 6.0% to 12.0%. Measurements Mean glucose concentration, measured by using continuous glucose monitoring and compared by race with HbA1c, glycated albumin, and fructosamine values. Results The mean HbA1c level was 9.1% in black persons and 8.3% in white persons. For a given HbA1c level, the mean glucose concentration was significantly lower in black persons than in white persons (P = 0.013), which was reflected in mean HbA1c values in black persons being 0.4 percentage points (95% CI, 0.2 to 0.6 percentage points) higher than those in white persons for a given mean glucose concentration. In contrast, no significant racial differences were found in the relationship of glycated albumin and fructosamine levels with the mean glucose concentration (P > 0.20 for both comparisons). Limitation There were too few participants with HbA1c levels less than 6.5% to generalize the results to such individuals. Conclusion On average,…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A1C levels may be 0.4% to 0.6% higher in Blacks and Hispanics compared with Whites, despite equivalent levels of hyperglycemia in those with T2D.11-17”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [17]
In the citing paper
“At the same average glucose values, HbA 1c was approximately 0.4% higher in the former compared with the latter.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [342]
In the citing paper
“A study in type 1 diabetes demonstrated a difference in the relationship between mean average glucose measured with CGM and HbA 1c in Black compared with White participants (342).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [342]
In the citing paper
“As discussed in section 2, “Diagnosis and Classification of Diabetes,” there is controversy regarding the clinical significance of differences in A1C by self-reported race and ethnicity (9)(10)(11)(12).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [9]
In the citing paper
“Studies have found that African American individuals have slightly higher A1C levels than non-Hispanic White or Hispanic people (22 -25).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [22]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Translating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812
Self-citationContinuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities
Rodbard, D. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0417 · Cited by 737 · cited 1×
“Food and Drug Administration approval after the study (25, 26).”
BackgroundThe Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685 · cited 2×
“Food and Drug Administration approval after the study (25, 26).”
BackgroundMethodHerman, W. H., Ma, Y., Uwaifo, G., Haffner, S., Kahn, S. E., Horton, E. S., Lachin, J. M., Montez, M. G., Brenneman, T., Barrett-Connor, E., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2003 · Cited by 574
Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c
Cohen, R. M., Franco, R. S., Khera, P. K., Smith, E. P., Lindsell, C. J., Ciraolo, P. J., Palascak, M. B., & Joiner, C. H. (2008) · Blood · doi:10.1182/blood-2008-04-154112 · Cited by 478 · cited 2×
“8) Age, n (%) 8 to <13 y 17 (14) 21 (20) 13 to <18 y 24 (19) 31 (29) 18 to <30 y 20 (16) 12 (11) 30 to <50 y 39 (31) 22 (21) ≥50 y 25 (20) 21 (20) Female, n (%) 62 (60) 55 (53) Annual household income, n (%) <$50 000 44 (59) 18 (23) $50 000 to <$100 000 24 (32) 23 (30) ≥$100 000 7 (9) 36 (47) Mean duration of diabetes…”
BackgroundThe fallacy of average: how using HbA1c alone to assess glycemic control can be misleading
Beck, R. W., Connor, C. G., Mullen, D. M., Wesley, D. M., & Bergenstal, R. M. (2017) · Diabetes Care · doi:10.2337/dc17-0636 · Cited by 477
Self-citationA1c versus glucose testing: a comparison
Sacks, D. B. (2011) · Diabetes Care · doi:10.2337/dc10-1546 · Cited by 461 · cited 2×
“8) Age, n (%) 8 to <13 y 17 (14) 21 (20) 13 to <18 y 24 (19) 31 (29) 18 to <30 y 20 (16) 12 (11) 30 to <50 y 39 (31) 22 (21) ≥50 y 25 (20) 21 (20) Female, n (%) 62 (60) 55 (53) Annual household income, n (%) <$50 000 44 (59) 18 (23) $50 000 to <$100 000 24 (32) 23 (30) ≥$100 000 7 (9) 36 (47) Mean duration of diabetes…”
BackgroundGlycemic control in youth with diabetes: the SEARCH for Diabetes in Youth Study
Petitti, D. B., Klingensmith, G. J., Bell, R. A., Andrews, J. S., Dabelea, D., Imperatore, G., Marcovina, S., Pihoker, C., Standiford, D., Waitzfelder, B., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.05.025 · Cited by 397
Self-citationTahara, Y., & Shima, K. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.440 · Cited by 380 · cited 3×
“Similar analyses to those described above were conducted for fructosamine and glycated albumin, using a maximum of 42 and 53 days of prior CGM data, respectively (28).”
MethodInfluentialRacial-ethnic disparities in management and outcomes among children with type 1 diabetes
Willi, S. M., Miller, K. M., DiMeglio, L. A., Klingensmith, G. J., Simmons, J. H., Tamborlane, W. V., Nadeau, K. J., Kittelsrud, J. M., Huckfeldt, P., Beck, R. W., et al. (2015) · Pediatrics · doi:10.1542/peds.2014-1774 · Cited by 367
Self-citation
Research works printed but not linked: 1
- Boltri JM, 2005, Ethn Dis, 15, 562
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
Metadata
- Authors
- Bergenstal, R. M., Gal, R. L., Connor, C. G., Gubitosi-Klug, R., Kruger, D., Olson, B. A., Willi, S. M., Aleppo, G., Weinstock, R. S., Wood, J., Rickels, M., DiMeglio, L. A., Bethin, K. E., Marcovina, S., Tassopoulos, A., Lee, S., Massaro, E., Bzdick, S., Ichihara, B., Markmann, E., McGuigan, P., Woerner, S., Ecker, M., Beck, R. W., & for the T1D Exchange Racial Differences Study Group*
- Affiliations
- Children's Hospital of Philadelphia (US)
- From International Diabetes Center Park Nicollet, Minneapolis, Minnesota; Jaeb Center for Health Research, Tampa, Florida; University Hospitals of Cleveland, Cleveland, Ohio; Henry Ford Health System, Detroit, Michigan; Children's Hospital of Philadelphia and Perelman School of Medicine and Rodebaugh Diabetes Center, University of Pennsylvania, Philadelphia, Pennsylvania; Northwestern University, Chicago, Illinois; SUNY Upstate Medical University, Syracuse, New York;
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2017-07-18
- Volume
- 167
- Issue
- 2
- Pages
- 95-102
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2625092562
- Semantic Scholar
- f0f7e81895f364d37c2c4682799f26717d554b9e
- Cited by
- 306
- References
- 40
- Citations by year
- 2026: 16 · 2025: 30 · 2024: 32 · 2023: 29 · 2022: 39 · 2021: 40 · 2020: 41 · 2019: 31 · 2018: 37 · 2017: 11
- FWCI
- 25.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Leona M. and Harry B. Helmsley Charitable Trust
- Abbott Diabetes Care
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- HbA1c, racial differences, type 1 diabetes, glycemic control, hemoglobin glycation, glycated albumin, fructosamine, Black patients, continuous glucose monitoring
- MeSH terms
- Glycated Serum Albumin, Adolescent, Adult, Black or African American, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Prospective Studies, Serum Albumin, United States, Blood Glucose Self-Monitoring, Glycation End Products, Advanced, Fructosamine, Black People, White People, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.